Think Lab: Regulatory Intelligence Exchange – What’s Changing & What Are You Seeing?
- Sharing the latest regulatory updates, agency interactions, and evolving expectations impacting radiopharmaceutical development across global markets.
- Comparing recent experiences with the FDA, EMA, and other health authorities to identify common themes, emerging trends, and areas of uncertainty.
- Collaboratively identifying practical strategies to navigate evolving CMC, clinical, and regulatory requirements while building a collective view of what to expect next.